Alkem Laboratories Ltd. - Research Center
539523 ALKEM Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 9,747.72 | 9,054.55 | 8,829.81 | 7,219.68 | 6,677.08 |
| Expenses | |||||
| Material consumed | 3,862.79 | 3,887.86 | 3,644.06 | 2,728.38 | 2,618.87 |
| Manufacturing expenses | 123.85 | 126.32 | 129.53 | 100.12 | 106.08 |
| Personnel expenses | 1,560.28 | 1,516.22 | 1,434.49 | 1,158.72 | 1,066.76 |
| Selling expenses | 667.83 | 704.94 | - | - | - |
| Adminstrative expenses | 1,567.84 | 1,442.26 | 1,811.37 | 1,283.53 | 1,417.72 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 7,782.59 | 7,677.60 | 7,019.45 | 5,270.75 | 5,209.43 |
| Operating profit | 1,965.13 | 1,376.95 | 1,810.36 | 1,948.93 | 1,467.65 |
| Other recurring income | 305.99 | 266.29 | 199.89 | 190.01 | 95.98 |
| Adjusted PBDIT | 2,271.12 | 1,643.24 | 2,010.25 | 2,138.94 | 1,563.63 |
| Financial expenses | 81.91 | 86.40 | 37.90 | 42.93 | 38.71 |
| Depreciation | 244.35 | 229.85 | 218.98 | 198.93 | 186.84 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 1,944.86 | 1,326.99 | 1,753.37 | 1,897.08 | 1,338.08 |
| Tax charges | 133.88 | 192.52 | 212.12 | 199.22 | 73.66 |
| Adjusted PAT | 1,810.98 | 1,134.47 | 1,541.25 | 1,697.86 | 1,264.42 |
| Non recurring items | -63.83 | - | - | -12.78 | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 1,747.15 | 1,134.47 | 1,541.25 | 1,685.08 | 1,264.42 |
| Earnigs before appropriation | 9,178.92 | 7,957.86 | 7,241.87 | 6,035.40 | 4,782.23 |
| Equity dividend | 538.04 | 526.09 | 418.48 | 334.78 | 285.49 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | 73.21 |
| Retained earnings | 8,640.88 | 7,431.77 | 6,823.39 | 5,700.62 | 4,423.53 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis